The Resource Comparative effectiveness of medications to reduce risk of primary breast cancer in women, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Oregon Evidence-based Practice Center ; investigators, Heidi D. Nelson ... [et al.], (electronic book)

Comparative effectiveness of medications to reduce risk of primary breast cancer in women, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Oregon Evidence-based Practice Center ; investigators, Heidi D. Nelson ... [et al.], (electronic book)

Label
Comparative effectiveness of medications to reduce risk of primary breast cancer in women
Title
Comparative effectiveness of medications to reduce risk of primary breast cancer in women
Statement of responsibility
prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Oregon Evidence-based Practice Center ; investigators, Heidi D. Nelson ... [et al.]
Contributor
Subject
Language
  • eng
  • eng
Summary
The purpose of this review is to evaluate the comparative effectiveness of tamoxifen citrate, raloxifene, and tibolone to reduce risk for primary breast cancer, assess the nature and magnitude of harms, and examine how benefits and harms vary by age, breast cancer risk status, and other factors. In addition, it examines issues related to clinical effectiveness, such as patient choice, concordance, adherence, and persistence of use, and evaluates methods to appropriately select patients for medication therapy to reduce risk of breast cancer
Member of
Cataloging source
DNLM
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Nelson, Heidi D.
  • United States
  • Oregon Health & Science University
Series statement
  • Comparative effectiveness review
  • AHRQ publication
Series volume
  • 17
  • 09-EHC028-EF
http://library.link/vocab/subjectName
  • Breast Neoplasms
  • Breast Neoplasms
  • Comparative Effectiveness Research
  • Tamoxifen
  • Raloxifene
  • Estrogen Receptor Modulators
  • United States
Label
Comparative effectiveness of medications to reduce risk of primary breast cancer in women, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Oregon Evidence-based Practice Center ; investigators, Heidi D. Nelson ... [et al.], (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references
Control code
1559526
Dimensions
unknown
Extent
1 online resource (1 PDF file (1 v. (various pagings)))
Form of item
online
Specific material designation
remote
Label
Comparative effectiveness of medications to reduce risk of primary breast cancer in women, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Oregon Evidence-based Practice Center ; investigators, Heidi D. Nelson ... [et al.], (electronic book)
Publication
Bibliography note
Includes bibliographical references
Control code
1559526
Dimensions
unknown
Extent
1 online resource (1 PDF file (1 v. (various pagings)))
Form of item
online
Specific material designation
remote

Library Locations

Processing Feedback ...